Regional Analysis

Global Flumazenil Market – Regional Analysis

On the basis of region, the global flumazenil market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Among regions, North America flumazenil market is expected to hold a dominant position during the forecast period, owing to increasing anxiety disorders in people. For instance, according to data published on March 26, 2021 by Centers for the Disease Control and Prevention in February 2021, the percentage of adults with symptoms of an anxiety or a depressive disorder increased from 36.4% to 41.5%. For treating anxiety disorder benzodiazepine is given to the patients in early stage. Benzodiazepines cause sedative effects among people. Flumazenil is used as a general anesthesia for complete or partial reversal of the sedative effects in patients, which it is expected to drive the growth of the global flumazenil market.

Furthermore, Europe is also estimated to witness significant growth in the flumazenil market, owing to increasing prevalence of liver cirrhosis disease. For instance, according to the data published on November 03, 2021 by the The Lancet Regional Health - Europe, between 2005 to 2018, a total of 2,302,171 patients had diagnosis of cirrhosis. A chronic disease of the liver such as cirrhosis causes degeneration of cells, inflammation, and fibrous thickening of tissue. Flumazenil is used for the treatment of cirrhosis in early stage, is expected to drive growth of the flumazenil market.

Figure 2: Global Flumazenil Market (US$ Bn), by Region, 2022